. Author manuscript; available in PMC: 2015 May 28.

Published in final edited form as: Eur J Nutr. 2012 Jun 26;52(3):937–948. doi: 10.1007/s00394-012-0401-x

Table 3. Myosin heavy chain composition and gene expression.

Parameters (n = 10)	Baseline	Post-intervention	P level
MHC I (%)	52.2 ± 17.0	50.4 ± 15.5	0.66
MHC IIa (%)	45.4 ± 19.3	46.8 ± 17.6	0.73
MHC IIx (%)	2.4 ± 7.6	2.8 ± 8.9	0.34
GAPDH mRNA (AU)	1.00 ± 0.74	1.94 ± 1.52	0.03^*
ACC mRNA (AU)	0.99 ± 0.52	1.21 ± 0.78	0.09^#
PGC1 α mRNA (AU)	0.96 ± 0.44	0.79 ± 0.53	0.04^*
CS mRNA (AU)	1.00 ± 0.38	0.98 ± 0.66	0.94
MondoA mRNA (AU)	0.36 ± 0.25	0.44 ± 0.34	0.06^#

MHC myosin heavy chain, GAPDH glyceraldehyde-3-phosphate dehydrogenase, ACC acetyl-CoA carboxylase α, PCG1α peroxisome proliferator-activated receptor-gamma coactivator 1 α, CS citrate synthase

P < 0.10,

P < 0.05